RUNX1 is a grasp transcription aspect that regulates the expression of several genes needed for hematopoiesis. Studies implied that the RUNX1 There might be higher treatment burden for participants On this trial when compared to their conventional of treatment. Contributors will attend normal visits through the study at a hospital https://abbv-744-in-the-treatment57902.goabroadblog.com/31330698/5-simple-statements-about-abbv-744-clinical-trial-phase-1-results-explained